We also sought to replicate this finding in the cohort of CRCs from LS patients (n = 35) by analysing median marker VAFs from tumours with MSH6 lesions, normalised to tumours with germline defects in other MMR genes. The gene discussed is MSH6; the disease is neoplasm.